Gene expression profiling in pure neural leprosy: insights into pathogenesis and diagnostic biomarkers

TL;DR

This study explores gene expression in pure neural leprosy to uncover insights into its causes and potential diagnostic markers.

Contribution

The study identifies novel transcriptomic alterations in pure neural leprosy, offering potential biomarkers for early diagnosis.

Findings

PCA of 500 differentially expressed genes clearly separated PNL samples from controls.

Downregulated genes were linked to neuronal development and autophagy, while upregulated genes were associated with immune responses.

Functional analysis revealed inflammasome activation and autophagy impairment in PNL.

Abstract

Leprosy may affect skin and nerves, leading to permanent disabilities and deformities. Pure neural leprosy (PNL) lacks skin lesions, complicating diagnosis. Moreover there is no a specific treatment to control neural damage. Transcriptomic profiling may reveals unique gene expression changes in PNL nerves, shedding light on immune response and pathogenesis. These findings may guide early diagnosis and improve patient outcome.

In the present study, we investigated the gene profiling of nerve samples from patients with PNL and revealed significant transcriptomic alterations compared to non-leprosy controls.

Principal Component Analysis (PCA) of the 500 most differentially expressed genes separated the groups, with 1,199 genes showing differential expression (|log2FC| ≥ 1, FDR ≤ 0.1). Downregulated genes included GAS2L2, TRIM67, IL1RAPL1, MAP1LC3B2, and NTNG1, implicated in neuronal development and autophagy, while upregulated genes were linked to immune responses. Functional analyses highlighted inflammasome activation and autophagy impairment in PNL, correlating with nerve inflammation and architecture loss.

We hope that our data will aid in identifying new markers, fostering strategies for early diagnosis, preventing disabilities, and improving the management of PNL patients.

Figures